aminopeptidas
n
apn
wide
express
transmembran
ectoenzym
implic
myriad
physiolog
process
specif
cell
type
tissu
origin
includ
cancer
cell
metastasi
angiogenesi
cholesterol
uptak
apoptosi
cell
migrat
skin
cell
particular
fibroblast
rel
high
level
express
migratori
capac
skin
cell
critic
outcom
wound
repair
success
wound
heal
requir
time
reepitheli
involv
reform
epithelium
wound
surfac
migrat
keratinocyt
failur
keratinocyt
undergo
proper
migrat
lead
chronic
nonheal
wound
presenc
excess
fibroblast
may
contribut
format
hypertroph
scar
keloid
aim
studi
investig
role
skin
cell
migrat
explor
potenti
therapeut
target
wound
heal
result
show
elev
express
apn
fibroblast
edg
wound
compar
unwound
cell
presenc
antibodi
reduc
migratori
activ
human
dermal
fibroblast
dosedepend
manner
respect
howev
antibodi
effect
keratinocyt
migrat
none
antibodi
use
studi
antiprolif
cytotox
effect
primari
human
keratinocyt
fibroblast
use
lgml
vitro
differenti
inhibit
migratori
capac
fibroblast
keratinocyt
present
opportun
antibodi
use
therapeut
agent
high
fibroblast
cellular
seen
fibroprolif
disord
wound
closur
requir
concert
effort
fibroblast
keratinocyt
follow
inflammatori
phase
basal
keratinocyt
wound
edg
begin
migrat
sheet
cover
wound
surfac
process
refer
reepitheli
keratinocyt
migrat
divid
gener
protect
layer
dermi
resid
dermal
fibroblast
deep
layer
reticular
dermi
hypodermi
well
fibroblast
differenti
bone
marrowderiv
mesenchym
stem
cell
circul
enter
wound
synthes
extracellular
matrix
compon
need
structur
repair
clinic
defect
keratinocyt
migrat
associ
chronic
nonheal
wound
presenc
excess
fibroblast
wound
seem
contribut
hypertroph
scar
format
aminopeptidas
n
apn
also
known
heavili
glycosyl
transmembran
peptidas
also
serv
receptor
coronavirus
transmiss
gastroenter
viru
human
coronaviru
ubiquit
express
endotheli
cell
monocyt
macrophag
dendrit
cell
neutrophil
fibroblast
fibroblastlik
cell
synoviocyt
epitheli
cell
synapt
membran
pericyt
dual
role
peptidecleav
enzym
cell
surfac
receptor
perform
myriad
function
tumor
cell
invas
prolifer
apoptosi
differenti
antigen
present
viral
infect
howev
due
short
intracellular
domain
lack
obviou
signal
motif
regard
signal
mediat
recent
sinc
function
expand
adhes
angiogenesi
monocyt
signal
instanc
wulfaeng
et
al
associ
express
enzymat
activ
wildtyp
diminish
cell
prolifer
migrat
invas
embryon
kidney
cell
meanwhil
pasqualini
et
al
demonstr
peptidas
activ
necessari
endotheli
invas
broad
function
widerang
express
pattern
suggest
function
transmembran
peptidas
may
well
depend
cell
type
tissu
origin
recent
studi
show
protein
express
fibroblast
three
time
high
keratinocyt
although
exact
role
skin
diseas
remain
elucid
preferenti
express
fibroblast
implic
tumor
cell
invas
make
target
potenti
valu
consid
fact
cell
migrat
critic
wound
heal
process
present
studi
investig
whether
play
role
cell
migrat
fibroblast
keratinocyt
examin
potenti
antibodi
therapeut
agent
high
cellular
seen
fibroprolif
disord
hypertroph
scar
cell
cultur
skin
punch
biopsi
obtain
inform
consent
patient
undergo
elect
surgeri
local
anesthesia
written
inform
consent
obtain
particip
studi
approv
univers
british
columbia
hospit
human
ethic
committe
conduct
accord
declar
helsinki
principl
detail
protocol
harvest
fibroblast
keratinocyt
skin
describ
previous
fibroblast
grown
dmem
fb
keratinocyt
ksfm
invitrogen
life
technolog
carlsbad
ca
supplement
bovin
pituitari
extract
lgml
epiderm
growth
factor
lgml
vitro
wound
scratch
assay
wound
scratch
assay
primari
human
fibroblast
keratinocyt
passag
seed
plate
fbsdmem
ksfm
supplement
bovin
pituitari
extract
lgml
epiderm
growth
factor
lgml
respect
confluenc
cell
wash
pb
twice
scratch
wound
made
across
well
pipett
tip
cell
treat
antibodi
lgml
santa
cruz
biotechnolog
santa
cruz
ca
serumfre
dmem
incub
photograph
taken
immedi
h
treatment
similarli
keratinocyt
treat
respect
antibodi
ksfm
photograph
taken
immedi
h
treatment
photograph
taken
use
zeiss
fluoresc
microscop
analyz
use
northern
eclips
imag
analysi
softwar
carl
zeiss
canada
toronto
quantit
assay
cultur
human
dermal
fibroblast
perform
accord
previous
publish
method
brief
assay
perform
triplic
use
nitroanilid
alapna
sigmaaldrich
oakvil
canada
phosphat
buffer
ph
chromogen
substrat
cell
incub
equal
amount
variou
antibodi
min
prior
assay
alapna
ad
concentr
mm
cell
reaction
stop
ad
acet
buffer
ph
min
incub
centrifug
min
absorb
supernat
detect
spectrophotometr
nm
cell
seed
clear
plate
densiti
cellswel
h
cultur
medium
replac
fresh
medium
serumfre
dmem
fibroblast
ksfm
keratinocyt
antibodi
ad
cell
individu
lgml
cell
incub
day
fibroblast
day
keratinocyt
co
atmospher
untreat
control
cell
antibodi
ad
cell
prolifer
evalu
use
mtt
cell
prolifer
assay
briefli
cell
rins
twice
pb
mgml
thiazolyl
blue
terzolium
bromid
sigmaaldrich
oakvil
ontario
canada
ad
well
h
incub
blue
crystal
solubil
ad
dmso
absorb
measur
nm
biotek
micropl
spectrophotomet
biotek
instrument
inc
winooski
vt
livedead
viabilitycytotox
assay
cell
viabil
dermal
fibroblast
keratinocyt
antibodi
treatment
examin
use
livedead
viabilitycytotox
kit
mammalian
cell
accord
manufactur
instruct
invitrogen
life
technolog
carlsbad
ca
live
cell
appear
green
result
intracellular
hydrolysi
convert
nonfluoresc
calcein
acetoxymethyl
ester
green
fluoresc
calcein
dead
cell
yield
red
fluoresc
result
permeat
ethidium
compromis
membran
dead
cell
immunohistochemistri
follow
scratch
assay
describ
cultur
fibroblast
fix
paraformaldehyd
pfa
min
ice
block
tb
contain
goat
serum
goat
albumin
sigmaaldrich
oakvil
ontario
canada
apn
vinculin
detect
use
rabbit
antiapn
santa
cruz
biotechnolog
santa
cruz
ca
mous
antivinculin
antibodi
sigmaaldrich
oakvil
ontario
canada
follow
rhodamineconjug
goat
antirabbit
millipor
billerica
alexa
goat
antimous
igg
invitrogen
eugen
respect
sampl
mount
prolong
gold
antifac
reagent
dapi
invitrogen
eugen
examin
zeiss
fluoresc
microscop
northern
eclips
imag
analysi
softwar
carl
zeiss
canada
toronto
data
express
mean
sd
ttest
use
compar
mean
valu
differ
treatment
p
valu
consid
statist
signific
studi
examin
role
fibroblast
migrat
primari
human
fibroblast
treat
antiapn
antibodi
differenti
enzymeinhibit
activ
vitro
wound
heal
assay
imag
cell
taken
h
posttreat
fig
total
number
cell
untreat
control
antibodytr
well
migrat
open
wound
area
end
incub
imag
human
fibroblast
taken
immedi
h
addit
antiapn
antibodi
lgml
vitro
wound
scratch
assay
scale
bar
lm
b
reduct
fibroblast
migrat
presenc
antibodi
fibroblast
migrat
evalu
count
number
cell
migrat
edg
wound
denud
area
treatment
express
percentag
cell
present
open
wound
area
rel
control
well
end
incub
n
p
c
enzymat
assay
endogen
human
fibroblast
treatment
variou
apn
antibodi
lgml
n
p
record
cell
migrat
evalu
percentag
cell
present
open
wound
area
treat
well
rel
control
well
end
incub
signific
differ
treatment
control
h
postscratch
howev
end
incub
control
wound
close
cell
show
reduct
migratori
activ
rel
control
wherea
antibodi
slow
cell
migrat
respect
fig
examin
whether
differenti
effect
antibodi
cell
migrat
inhibit
relat
abil
inhibit
enzymat
activ
endogen
human
dermal
fibroblast
treat
concentr
antibodi
use
scratch
assay
enzymat
activ
measur
use
chromogen
substrat
nitroanilid
shown
fig
reduc
endogen
enzymat
activ
respect
inhibitori
effect
examin
differ
dose
antibodi
shown
fig
inhibit
fibroblast
migrat
wound
dosedepend
manner
specif
percent
inhibit
fibroblast
migrat
result
ad
lgml
respect
although
effect
inhibit
fibroblast
migrat
critic
aspect
prevent
hypertroph
scar
format
similar
effect
keratinocyt
may
lead
failur
wound
closur
reason
influenc
antibodi
keratinocyt
migrat
also
examin
monolay
confluent
human
keratinocyt
similarli
scratch
describ
cell
migratori
activ
observ
h
time
control
scratch
close
shown
fig
keratinocyt
migrat
appear
littl
affect
antibodi
even
h
keratinocyt
move
time
point
data
shown
gener
time
lag
keratinocyt
migrat
wound
correl
report
optim
time
h
keratinocyt
movement
figur
show
percent
inhibit
keratinocyt
migrat
respect
significantli
differ
control
ensur
inhibitori
effect
fibroblast
migrat
due
cell
growth
retard
mtt
assay
perform
studi
whether
antibodi
effect
cell
prolifer
expos
confluent
cell
cultur
fibroblast
individu
antibodi
period
h
cell
prolifer
measur
term
fluoresc
intens
sampl
result
show
antibodi
antiprolif
effect
fibroblast
prolifer
rel
control
cell
presenc
respect
fig
left
neg
effect
cell
prolifer
may
impair
outcom
wound
heal
mtt
assay
similarli
perform
keratinocyt
examin
effect
keratinocyt
prolifer
consider
fact
keratinocyt
requir
time
cover
wound
surfac
vitro
scratch
assay
extend
period
antibodi
exposur
day
keratinocyt
mtt
assay
cell
prolifer
presenc
respect
indic
subtl
effect
keratinocyt
prolifer
fig
right
howev
reduct
significantli
differ
control
ensur
safeti
antibodi
therapeut
agent
cytotoxicitycel
viabil
assay
perform
assay
util
two
reagent
calcein
ethidium
label
live
dead
cell
respect
calcein
esteras
substrat
hydrolyz
intracellularli
calcein
show
live
cell
green
ethidium
red
fluoresc
nucleic
acid
stain
capabl
permeat
compromis
membran
dead
cell
shown
red
photo
present
fig
superimpos
imag
live
dead
cell
fibroblast
upper
panel
keratinocyt
cultur
lower
panel
fibroblast
incub
antibodi
day
prior
cytotox
assay
keratinocyt
expos
antibodi
longer
period
day
live
dead
cell
count
visual
percentag
live
cell
calcul
convert
percent
cell
viabil
take
percentag
live
cell
control
sampl
antibodi
produc
neglig
cytotox
effect
fibroblast
less
reduct
cell
number
three
antibodi
fig
left
although
differ
signific
antibodi
seem
pronounc
cytotox
effect
keratinocyt
caus
reduct
cell
viabil
compar
control
effect
slightli
stronger
reduc
cell
number
respect
fig
right
protein
express
fibroblast
cell
migrat
examin
use
independ
vitro
model
shown
fig
fibroblast
seed
differ
cell
densiti
rang
cell
per
cm
cultur
normal
condit
h
prior
lysi
densitydepend
protein
express
observ
follow
immunoblot
analysi
express
peak
cell
cm
cell
like
prolif
migratori
phase
growth
express
quickli
diminish
fibroblast
reach
confluenc
higher
cell
densiti
addit
analyz
express
fibroblast
migrat
assay
scratch
assay
confluent
monolay
maxim
densiti
wound
remov
sever
wide
band
cell
x
dimens
migrat
fibroblast
open
wound
area
occur
within
h
cell
lyse
sdspage
western
blot
analysi
compar
uninjur
cell
cell
popul
migratori
fibroblast
display
higher
express
fig
evalu
effect
antibodi
keratinocyt
migrat
imag
human
keratinocyt
taken
immedi
h
addit
antibodi
lgml
vitro
wound
scratch
assay
scale
bar
lm
b
keratinocyt
migrat
affect
antibodi
addit
keratinocyt
migrat
evalu
count
number
cell
migrat
edg
wound
denud
area
treatment
express
percentag
cell
present
open
wound
area
rel
control
well
end
incub
n
p
protein
fig
express
protein
individu
migratori
cell
examin
scratch
wound
made
across
confluent
monolay
dermal
fibroblast
vinculin
express
use
indic
cell
motion
shown
upper
panel
fig
express
highest
activ
migrat
cell
within
denud
wound
area
lowest
stationari
cell
distant
wound
scratch
shown
merg
imag
stain
cell
popul
antivinculin
antibodi
confirm
signific
overlap
express
vinculin
higher
magnif
imag
shown
lower
panel
fig
concept
inhibit
cell
migrat
reduc
apn
express
activ
use
sirna
chemic
inhibitor
neutral
antibodi
proven
success
tumor
cell
ovarian
carcinoma
cell
lymphocyt
endotheli
cell
instanc
minaosorio
et
al
util
antibodi
induc
adhes
monocyt
endotheli
cell
studi
took
advantag
preferenti
express
fibroblast
prove
first
time
antibodi
use
effect
reduc
migrat
fibroblast
open
scratch
wound
without
slow
keratinocyt
movement
similarli
previou
find
use
human
lung
cancer
cell
inhibitori
effect
antibodi
cell
migrat
partli
due
suppress
enzymat
activ
shown
enzymat
assay
result
potent
cell
migrationinhibit
antibodi
also
effect
enzymat
inhibitor
two
antibodi
similar
effect
cell
migrat
inhibit
vs
suppress
enzymat
activ
differ
vs
indic
observ
cell
migrationinhibitori
effect
entir
depend
enzymat
activ
one
possibl
reason
differenti
bind
avid
monoclon
vs
polyclon
importantli
fibroblast
keratinocyt
abl
maintain
healthi
state
even
day
exposur
prepar
antibodi
better
posit
vivo
clinic
use
may
requir
report
direct
correl
enzym
activ
cell
prolifer
hacat
cell
observ
antiprolif
effect
reconfirm
find
neither
fibroblast
keratinocyt
prolifer
affect
presenc
thu
effect
dosag
low
lg
ml
vitro
unlik
reduc
viabil
fibroblast
keratinocyt
impair
normal
wound
heal
keratinocyt
migrat
known
involv
format
lamellipodia
loss
contact
hemidesmosom
desmosom
chang
keratin
phenotyp
redistribut
actin
cytoskeleton
lamellipodia
molecular
mechan
cellular
event
undertaken
migrat
fibroblast
poorli
understood
nevertheless
fibroblast
keratinocyt
like
adopt
distinct
regulatori
mechan
cell
migrat
due
differ
extern
environ
surround
cell
thu
order
understand
antibodi
affect
migratori
capac
fibroblast
keratinocyt
work
mechanist
detail
involv
fibroblast
migrat
need
meanwhil
plausibl
rational
suggest
differenti
effect
might
due
enhanc
antibodi
respons
fibroblast
higher
level
express
activ
keratinocyt
densitydepend
express
pattern
indic
highest
protein
express
cell
cm
allow
fibroblast
achiev
optim
cellcel
contact
migrat
thu
requir
higher
express
kehlen
colleagu
shown
direct
cellcel
contact
lymphocyt
fibroblastlik
synoviocyt
result
increas
mrna
cell
surfac
protein
lymphocyt
regard
fibroblast
seed
lower
cell
densiti
cellcm
express
less
possibl
due
lack
cellcel
contact
limit
space
higher
cell
densiti
cellcm
prevent
cell
movement
contact
inhibit
immunohistochem
stain
cell
migrat
artifici
creat
scratch
wound
show
compar
stationari
cell
activ
migrat
cell
indic
vinculin
express
express
significantli
observ
support
analyz
protein
express
western
blot
b
equal
number
scratch
wound
made
x
direct
confluent
monolay
dermal
fibroblast
unwound
confluent
cell
use
control
cell
lysat
obtain
follow
overnight
incub
analyz
protein
express
western
blot
bactin
express
use
load
control
panel
c
scratch
wound
made
across
confluent
monolay
primari
human
fibroblast
cell
stain
antivinculin
antibodi
antibodi
follow
alexa
rhodamin
secondari
antibodi
respect
dot
line
upper
panel
scale
bar
lm
show
border
scratch
higher
magnif
scale
bar
lm
imag
shown
lower
panel
mol
cell
biochem
find
signific
role
fibroblast
motil
gener
patholog
skin
condit
hypertroph
scar
keloid
high
cellular
vessel
densiti
remain
condit
well
remodel
phase
normal
wound
heal
time
apoptosi
significantli
reduc
tissu
cellular
blood
suppli
earli
remodel
phase
believ
antibodi
play
key
therapeut
role
reduc
wound
cellular
inhibit
fibroblast
migrat
wound
well
revers
high
vascular
block
migrat
endotheli
cell
conclus
antibodi
may
use
therapeut
agent
normal
fibroblast
cellular
vessel
densiti
elev
mani
fibroprolif
disord
